PURPOSE: Contrast-enhanced ultrasonography (CEUS) is an appealing alternative to computed tomography angiography (CTA) for the follow-up of patients who underwent endovascular abdominal aortic aneurysm repair (EVAR). We sought to evaluate the accuracy of CEUS compared with a particularly tailored protocol of CTA performed with a 64-row multidetector CT. MATERIALS AND METHODS: The study prospectively enrolled 88 consecutive patients for CEUS and CTA imaging during follow-up after EVAR, yielding 142 paired examinations. The outcome is represented by three main goals: identification and characterisation of endoleaks, evaluation of graft patency and measurement of aneurysm diameter. Triple-phase CTA was the gold standard. RESULTS: Sensitivity and specificity of CEUS compared with CTA in endoleak and graft patency evaluation were 91.89% and 100% and 72% and 100%, respectively. A very high correlation between CTA and CEUS diameter measurements was established. CEUS did not appear superior to CTA in endoleak detection, probably because a tailored CTA protocol with a delayed phase (180 s) allows detection of low-flow endoleaks. CONCLUSIONS: Patient management was not different following CEUS and CTA results. CTA cannot yet be completely replaced, but several limitations (radiation exposure, contrast agent) encourage redefining the routine follow-up imaging modality. We suggest an algorithm of surveillance alternating CTA and CEUS.
PURPOSE: Contrast-enhanced ultrasonography (CEUS) is an appealing alternative to computed tomography angiography (CTA) for the follow-up of patients who underwent endovascular abdominal aortic aneurysm repair (EVAR). We sought to evaluate the accuracy of CEUS compared with a particularly tailored protocol of CTA performed with a 64-row multidetector CT. MATERIALS AND METHODS: The study prospectively enrolled 88 consecutive patients for CEUS and CTA imaging during follow-up after EVAR, yielding 142 paired examinations. The outcome is represented by three main goals: identification and characterisation of endoleaks, evaluation of graft patency and measurement of aneurysm diameter. Triple-phase CTA was the gold standard. RESULTS: Sensitivity and specificity of CEUS compared with CTA in endoleak and graft patency evaluation were 91.89% and 100% and 72% and 100%, respectively. A very high correlation between CTA and CEUS diameter measurements was established. CEUS did not appear superior to CTA in endoleak detection, probably because a tailored CTA protocol with a delayed phase (180 s) allows detection of low-flow endoleaks. CONCLUSIONS:Patient management was not different following CEUS and CTA results. CTA cannot yet be completely replaced, but several limitations (radiation exposure, contrast agent) encourage redefining the routine follow-up imaging modality. We suggest an algorithm of surveillance alternating CTA and CEUS.
Authors: Alla M Rozenblit; Michael Patlas; Ayala T Rosenbaum; Takao Okhi; Frank J Veith; Mitchell P Laks; Zina J Ricci Journal: Radiology Date: 2003-04-03 Impact factor: 11.105
Authors: Marcus J Dill-Macky; Stephanie R Wilson; Yarron Sternbach; John Kachura; Thomas Lindsay Journal: AJR Am J Roentgenol Date: 2007-03 Impact factor: 3.959
Authors: Jan A Ten Bosch; Ellen V Rouwet; Cecile T H Peters; Linda Jansen; Hence J M Verhagen; Martin H Prins; Joep A W Teijink Journal: J Vasc Interv Radiol Date: 2010-04-02 Impact factor: 3.464
Authors: Brian R Beeman; Lynne M Doctor; Kevin Doerr; Sandy McAfee-Bennett; Matthew J Dougherty; Keith D Calligaro Journal: J Vasc Surg Date: 2009-08-05 Impact factor: 4.268
Authors: Georgios I Karaolanis; Constantine N Antonopoulos; Efstratios Georgakarakos; Georgios D Lianos; Michail Mitsis; Georgios K Glantzounis; Athanasios Giannoukas; George Kouvelos Journal: J Clin Med Date: 2022-06-23 Impact factor: 4.964
Authors: Daniel Marelli; Edward Woo; Michael Watson; Paul Fedalen; Grace Wang; Megan Stallings; Ronald Fairman; John Mannion Journal: Can J Surg Date: 2013-10 Impact factor: 2.089